Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
1.170
-0.215 (-15.52%)
At close: Apr 1, 2025, 4:00 PM
1.190
+0.020 (1.71%)
After-hours: Apr 1, 2025, 7:35 PM EDT

Cabaletta Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Net Income
--67.68-52.98-46.29-33.34
Upgrade
Depreciation & Amortization
-1.431.180.730.35
Upgrade
Loss (Gain) From Sale of Investments
--1.22-0.220.060.12
Upgrade
Stock-Based Compensation
-11.346.95.84.39
Upgrade
Other Operating Activities
-2.483.04--
Upgrade
Change in Accounts Payable
-1.68-0.030.980.56
Upgrade
Change in Other Net Operating Assets
--1.57-4.274.611.15
Upgrade
Operating Cash Flow
--53.55-46.38-34.11-26.77
Upgrade
Capital Expenditures
--0.69-2.45-1.17-0.64
Upgrade
Investment in Securities
--21.76-24.767.17-7.35
Upgrade
Investing Cash Flow
--22.45-27.226-7.98
Upgrade
Issuance of Common Stock
-187.6332.9848.90.17
Upgrade
Other Financing Activities
-----0.19
Upgrade
Financing Cash Flow
-187.6332.9848.9-0.02
Upgrade
Net Cash Flow
-111.63-40.6220.79-34.78
Upgrade
Free Cash Flow
--54.24-48.83-35.28-27.41
Upgrade
Free Cash Flow Per Share
--1.32-1.66-1.37-1.18
Upgrade
Levered Free Cash Flow
--30.41-29.25-17.82-15.53
Upgrade
Unlevered Free Cash Flow
--30.41-29.25-17.82-15.53
Upgrade
Change in Net Working Capital
--4.171.04-5.75-1.51
Upgrade
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q